GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Seattle Genetics CEO on ADCETRIS Drug For Hodgkins

Tue 05 Jun 12 | 06:45 PM ET
Clay Siegall, Seattle Genetics president & CEO, discusses his company's latest drug developments for non-hodgkins lymphoma and hodgkins lymphoma, and its opportunity to be a "$1 billion plus product on its own."
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Luxury rental boom ... in Jersey
Fri 18 Apr 14 | 12:00 PM ET
Latest Videos
Great growth expectations
Fri 18 Apr 14 | 11:00 AM ET
Latest Videos
Remodeling & insurance costs
Fri 18 Apr 14 | 09:00 AM ET
Go
Displaying results for: Latest Video | US